Addressing obesity has become both a critical focus and a persistent challenge in medical research
D., Stierman, B., & Ogden, C
For eligible patients, it may be prescribed as part of a personalized, clinician-guided weight-management plan
A 2024 to 2025 retrospective cohort of roughly 39 million eligible adults found fewer than 3 percent of eligible people with obesity received a GLP-1 prescription, and after adjustment Black patients had lower odds of receiving semaglutide than White patients (adjusted odds ratio about 0.8), with even lower odds for Hispanic and Asian patients
10.1038/s41586-018-0049-7 [DOI] [PMC free article] [PubMed] [Google Scholar] Yanovski, S
Its essential to remember that the body works as a system